Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
Figure 5
20 training sets and 7 test sets using SVM, MLR models and Bayesian network for predicted activity. of SVM = 0.9207, MLR = 0.9124, and Bayesian = 0.6709.
